# Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer

> **NCT04989153** · — · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 5000 (estimated)

## Conditions studied

- Gastric Cancer
- Precancerous Lesion
- Helicobacter Pylori Infection

## Interventions

- **DIAGNOSTIC_TEST:** pepsinogen

## Key facts

- **NCT ID:** NCT04989153
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03-05
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-06
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04989153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04989153, "Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04989153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*